Skip to main content
Top of the Page
ABT

Policy & Advocacy

Our Vision

Shaping policy for a thriving life science sector

AusBiotech is committed to supporting the development of public policy that enables the growth of our thriving life sciences sector.



Why politics and policy matters for life sciences

Australia’s life sciences sector operates in a dynamic and complex policy and geopolitical environment:

Research and clincial trials

Regulation and market access

Investment and captial

Global trade and supply chains

Skilled and future ready workforce

Coordinated advocacy and policy development ensures policy keeps pace with innovation and unlocks new opportunities for the sector.

A unified voice to government

We work with the sector to bring industry insight and priorities into key policy discussions and decisions through:

  • Sector-wide policy platforms and advocacy priorities
  • Federal and State government policy submissions
  • Direct engagement with ministers and departments
  • Strategic policy roundtables and forums
  • Cross-sector coalition building
  • International trade and market access advocacy
  • Regulatory reform engagement including TGA and R&D Tax Incentive


Image description

What we are advocating for

In partnership with our members, AusBiotech has identified four overarching national policy priorities.

Government Strategy

ONE

Develop Australia's first whole-of-government National Life Sciences Strategy to set policy priorities, eliminate gaps and overlaps, and bring Australia in line with other countries competing for global investment and building their national capabilities.

TWO

Establish a whole-of-government Life Sciences Council in partnership with industry to drive the strategy, address broader sector challenges, ensure value for investment and achievement of the government's health, economic, security and employment priorities.

THREE

Recognise life sciences as a priority under the Future Made In Australia Act, creating the focus and cross-portfolio coordination required to maximise the sector's contribution to Australia's economic resilience, national security and health.

FOUR

Invest in data to drive innovation to better understand global interdependencies and improve policy and decision making.

Alongside our four overarching policy priorities, we continue to advocate on a range of ongoing and emerging policy issues affecting our sector.

Your unified, member-led voice to government

We partner with our members, from universities, research institutes, start-ups, SMEs, large Australian and international companies, investors and service providers, to advocate and shape government policy.

Our advocacy is shaped directly by member input

We do this through our:

  • State Committees
  • Advisory Groups
  • Policy Roundtables
  • In-person workshops
  • Targeted webinars
  • Insight through surveys and discussions

We consult with our members across multiple submissions and policy consultations — ensuring advocacy reflects real-world sector challenges.


Recent Submissions

AusBiotech regularly develops evidence-based submissions to government consultations, ensuring the voices and priorities of our members and Australia’s life sciences sector are represented in policy decisions.

Help shape what comes next

Your insights and expertise strengthens sector advocacy.

Back to Top